APA Alıntı

Dessai, S. B., Chakraborty, S., Babu, T. V. S., Nayanar, S., Bhattacharjee, A., Jones, J., . . . Patil, V. M. (2016). Tolerance of weekly metronomic paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin. South Asian J Cancer.

Chicago Stili Alıntı

Dessai, S. B., S. Chakraborty, T. V. S. Babu, S. Nayanar, A. Bhattacharjee, J. Jones, S. Balasubramanian, ve Vijay M. Patil. "Tolerance of Weekly Metronomic Paclitaxel and Carboplatin As Neoadjuvant Chemotherapy in Advanced Ovarian Cancer Patients Who Are Unlikely to Tolerate 3 Weekly Paclitaxel and Carboplatin." South Asian J Cancer 2016.

MLA Alıntı

Dessai, S. B., et al. "Tolerance of Weekly Metronomic Paclitaxel and Carboplatin As Neoadjuvant Chemotherapy in Advanced Ovarian Cancer Patients Who Are Unlikely to Tolerate 3 Weekly Paclitaxel and Carboplatin." South Asian J Cancer 2016.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..